The 17 analysts offering 1 year price forecasts for NSIS/N have a max estimate of — and a min estimate of —.
Analyst rating
Based on 19 analysts giving stock ratings to NSIS/N in the past 3 months.
EPS
0.00
Reported
Estimate
Reported
Estimate
Surprise
Revenue
0.00
Reported
Estimate
Reported
Estimate
Surprise
Be warned
This info isn't a recommendation for what you should personally do, so please don't take the data as investment advice. As with any trade, always look first, then leap. Read more in the Terms of Use.
Frequently Asked Questions
NSIS/N EPS for the last quarter is 7.85 MXN despite the estimation of 11.27 MXN. In the next quarter EPS is expected to reach 14.03 MXN. Track more of NOVONESIS (NOVOZYMES) B financials and stay on top of what is up with the company.
According to analysts, NSIS/N price target is 1,437.95 MXN with a max estimate of 1,689.15 MXN and a min estimate of 1,049.23 MXN. Check if this forecast comes true in a year, meanwhile watch NOVONESIS (NOVOZYMES) B stock price chart and keep track of the current situation with NSIS/N news and stock market news.
We've gathered opinions of 19 analysts rating NSIS/N stock in the past 3 months. Most of them backed up the strong buy trend, and after taking into account other opinions, the overall rating was calculated as buy. Note that it's not a trading advice — your own analysis is still required.